Urenco Isotopes provides the world with stable and medical isotopes for medical, research and industry uses.
Visit our Isotopes websiteSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur increased order book and solid financial and operational performance provide basis for future growth.
Read our latest report21 January 2019
Urenco, an international supplier of uranium enrichment services, today announces the appointment of Boris Schucht as the company’s new Chief Executive Officer.
Mr Schucht will take up the position of Chief Executive Officer in May 2019, at which time he will be appointed to the Urenco Limited Board.
He joins Urenco from 50Hertz, the North-East German Transmission System Operator, where he has held the position of Chief Executive Officer since 2010. Mr Schucht previously held a number of senior executive positions within the energy sector across Germany and Europe, including WEMAG AG and the Vattenfall Group.
Mr Schucht said of his appointment:
“I look forward to leading Urenco and sustaining the long term success of the business, while enhancing our support for the industry. Urenco plays a pivotal role in the production of reliable, low carbon nuclear power. As the demand for electricity increases, it is essential that we have a secure supply of energy. I am personally convinced that combatting global climate change requires a balanced energy mix in which nuclear plays a vital role.”
Mr Schucht succeeds Thomas Haeberle who will step down and retire from his position of Chief Executive Officer.
About Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries